Innovative approaches to conducting proof-of-concept trials could accelerate the evaluation of repurposed drugs. Drawing lessons from repurposing efforts for COVID-19 therapies, here we present a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results